Journal
CLINICAL INFECTIOUS DISEASES
Volume 53, Issue 7, Pages E77-E80Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cir501
Keywords
-
Categories
Ask authors/readers for more resources
Parainfluenza virus (PIV) can cause significant morbidity after allogeneic stem cell transplantation (SCT). We report the first use of inhaled DAS181 for PIV in an allogeneic SCT recipient. Symptoms, oxygenation, and pulmonary function tests improved. Nasopharyngeal samples showed a reduction in viral load. DAS181 should be systematically evaluated for severe PIV infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available